This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hintze, T. H. Articles by Vatner, S. F. Search for Related Content PubMed PubMed Citation Articles by Hintze, T. H. Articles by Vatner, S. F.

Circulation, Vol 68, 1321-1327, Copyright © 1983 by American Heart Association

ARTICLES

Dipyridamole dilates large coronary arteries in conscious dogs

TH Hintze and SF Vatner

The effects of 0.25 mg/kg dipyridamole on left ventricular (LV) pressures, LV dP/dt, heart rate, aortic pressures, left circumflex coronary blood flow, and left circumflex coronary arterial diameters and on calculations of late diastolic coronary resistance and large coronary cross-sectional area were studied in 15 conscious dogs. Injection of dipyridamole, a drug that has a mechanism of action dependent on myocardial adenosine production, caused sustained increases in mean coronary blood flow (244 +/- 28%), large coronary arterial cross-sectional area (28 +/- 3.2%), heart rate (32 +/- 3.6%), and LV dP/dt (23 +/- 3.0%) and reductions in late diastolic coronary resistance (73 +/- 2.4%) and mean arterial pressure (14 +/- 1.9%). Neither beta-adrenergic-receptor blockade alone nor in conjunction with constant heart rate affected the dilation of large coronary arteries to dipyridamole significantly. Ganglionic blockade with hexamethonium also had little effect on the response of large and small coronary vessels to dipyridamole. Surprisingly neither beta-adrenergic-receptor nor ganglionic blockade abolished the rise in LV dP/dt observed after dipyridamole. Aminophylline, however, effectively eliminated the dilation of large coronary arteries and resistance coronary vessels in response to dipyridamole. In summary, as long as dipyridamole does not induce severe sustained hypotension it exerts potent effects on both coronary arterial resistance and large coronary arteries in the conscious dog. The coronary dilation is independent of reflex adrenergic activation, but appears dependent on myocardial adenosine production.

This article has been cited by other articles:

				H. Ito, T. Kinoshita, Y. Tamura, I. Yokoyama, and H. Iida Effect of Intravenous Dipyridamole on Cerebral Blood Flow in Humans : A PET Study Stroke, August 1, 1999; 30(8): 1616 - 1620. [Abstract] [Full Text] [PDF]

				M. Kozakova, C. Palombo, L. Pratali, G. Pittella, F. Galetta, and A. L'Abbate Mechanisms of Coronary Flow Reserve Impairment in Human Hypertension: An Integrated Approach by Transthoracic and Transesophageal Echocardiography Hypertension, February 1, 1997; 29(2): 551 - 559. [Abstract] [Full Text]

				C. Lu, E. Picano, A. Pingitore, R. Sicari, R. Tongiani, M. Baratto, C. Palmieri, M. Marzilli, and A. L'Abbate Complex Coronary Artery Lesion Morphology Influences Results of Stress Echocardiography Circulation, March 15, 1995; 91(6): 1669 - 1675. [Abstract] [Full Text]

				K. Matsumura, Y. Okuda, T. Ito, T. Hirano, K. Takeda, and N. Yamaguchi Coronary Angiography of Kawasaki Disease with the Coronary Vasodilator Dipyridamole: Assessment of Distensibility of Affected Coronary Arterial Wall Angiology, February 1, 1988; 39(2): 141 - 147. [Abstract] [PDF]